ATE554746T1 - Pharmazeutische zusammensetzungen mit cyclosporin - Google Patents

Pharmazeutische zusammensetzungen mit cyclosporin

Info

Publication number
ATE554746T1
ATE554746T1 AT06818907T AT06818907T ATE554746T1 AT E554746 T1 ATE554746 T1 AT E554746T1 AT 06818907 T AT06818907 T AT 06818907T AT 06818907 T AT06818907 T AT 06818907T AT E554746 T1 ATE554746 T1 AT E554746T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
cyclosporin
group
containing cyclosporin
Prior art date
Application number
AT06818907T
Other languages
English (en)
Inventor
Manfred Keller
Aslihan Akkar
Ralf Mehrwald
Original Assignee
Pari Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pari Pharma Gmbh filed Critical Pari Pharma Gmbh
Application granted granted Critical
Publication of ATE554746T1 publication Critical patent/ATE554746T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06818907T 2005-12-06 2006-11-29 Pharmazeutische zusammensetzungen mit cyclosporin ATE554746T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005058252 2005-12-06
DE102006051512A DE102006051512A1 (de) 2005-12-06 2006-10-31 Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
PCT/EP2006/011459 WO2007065588A1 (de) 2005-12-06 2006-11-29 Pharmazeutische zusammensetzungen mit cyclosporin

Publications (1)

Publication Number Publication Date
ATE554746T1 true ATE554746T1 (de) 2012-05-15

Family

ID=37682529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06818907T ATE554746T1 (de) 2005-12-06 2006-11-29 Pharmazeutische zusammensetzungen mit cyclosporin

Country Status (10)

Country Link
US (2) US9161963B2 (de)
EP (1) EP1968538B1 (de)
AT (1) ATE554746T1 (de)
AU (1) AU2006322342B2 (de)
BR (1) BRPI0619475B8 (de)
CA (1) CA2639696C (de)
DE (1) DE102006051512A1 (de)
ES (1) ES2382884T3 (de)
RU (1) RU2421209C2 (de)
WO (1) WO2007065588A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1848431T3 (en) 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
ES2594368T3 (es) 2005-12-08 2016-12-19 Insmed Incorporated Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
AU2007212271B2 (en) 2006-02-09 2012-11-01 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
BRPI0709016A2 (pt) 2006-03-23 2011-06-21 Macusight Inc formulações e métodos para doenças ou condições relacionadas com a permeabilidade vascular
EP2139492A1 (de) * 2007-03-30 2010-01-06 Fovea Pharmaceuticals SA Verfahren zur behandlung von neovaskulären augenerkrankungen
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
TW200904485A (en) * 2007-05-18 2009-02-01 Alcon Res Ltd Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions
WO2009046967A1 (en) * 2007-10-08 2009-04-16 Fovea Pharmaceuticals Sa Aqueous ophthalmic formulations
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
US9351995B1 (en) * 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
CN104039308B (zh) * 2011-11-15 2018-06-05 阿勒根公司 环孢菌素a形式2的可热压性悬浮液
HRP20220158T1 (hr) 2012-05-21 2022-04-15 Insmed Incorporated Sustavi za liječenje plućnih infekcija
US20140023696A1 (en) * 2012-07-20 2014-01-23 Frederick Timothy Guilford Treatment for idiopathic pulmonary fibrosis
CN104884047A (zh) 2012-11-29 2015-09-02 英斯梅德股份有限公司 稳定的万古霉素制剂
EP3520773A1 (de) * 2013-03-14 2019-08-07 PanOptica, Inc. Augenformulierungen für wirkstofffreisetzung im hinteren segment des auges
US9387151B2 (en) 2013-08-20 2016-07-12 Anutra Medical, Inc. Syringe fill system and method
CA2949078C (en) 2014-05-15 2022-09-20 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
KR101587412B1 (ko) * 2014-10-17 2016-01-21 주식회사 휴온스 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물
EP3069711A1 (de) 2015-03-16 2016-09-21 PARI Pharma GmbH Cyclosporinformulierungen zur verwendung bei der vorbeugung oder behandlung von pulmonaler chronischer transplantatabstossung
AU2018287044A1 (en) 2017-06-23 2020-02-13 Aki Therapeutics Aps Compositions for the prevention and treatment of acute renal injury
EP3681479B1 (de) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Natriumhydrogencarbonat zur verwendung in der behandlung von gicht und verwandten erkrankungen
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
PL3773664T3 (pl) 2018-04-11 2024-09-02 Breath Therapeutics Gmbh Preparaty cyklosporyny do stosowania w leczeniu zespołu zarostowego zapalenia oskrzelików (bos)
CN113038930A (zh) 2018-06-27 2021-06-25 呼吸治疗公司 冻干形式的药物组合物
AU2019294975A1 (en) * 2018-06-27 2021-01-14 Breath Therapeutics Gmbh Inhalable compositions comprising macrocyclic immunosuppressants
EA202092892A1 (ru) * 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты
KR20220125259A (ko) 2019-12-23 2022-09-14 잠본쏘시에떼퍼아찌오니 흡입성 면역억제 활성 성분을 포함하는 분산액의 제조 방법
IT202200016614A1 (it) * 2022-08-04 2024-02-04 Mimetech S R L Udonitrectag e sue formulazioni ad uso topico per l’uso nel trattamento di patologie dermatologiche

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2577049B2 (ja) 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
GB9105705D0 (en) 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
AU709783B2 (en) 1994-03-14 1999-09-09 Abbott Laboratories Aerosol drug formulations containing vitamin E
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
US5958378A (en) * 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
TW497974B (en) 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
JP2000514085A (ja) 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
ATE404172T1 (de) * 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
US20020006901A1 (en) 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
AU2003237863A1 (en) * 2002-05-20 2003-12-12 Research Development Foundation Aerosol drug inhibition of lung metastases
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
EP1712220A1 (de) 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmazeutische Aerosolzusammensetzung

Also Published As

Publication number Publication date
RU2421209C2 (ru) 2011-06-20
CA2639696A1 (en) 2007-06-14
WO2007065588A8 (de) 2007-08-30
RU2008125986A (ru) 2010-01-20
CA2639696C (en) 2015-06-02
WO2007065588A1 (de) 2007-06-14
EP1968538A1 (de) 2008-09-17
US9161963B2 (en) 2015-10-20
DE102006051512A1 (de) 2007-06-14
US20130177626A1 (en) 2013-07-11
AU2006322342A1 (en) 2007-06-14
AU2006322342B2 (en) 2012-05-24
BRPI0619475B1 (pt) 2022-01-11
EP1968538B1 (de) 2012-04-25
ES2382884T3 (es) 2012-06-14
US20090169607A1 (en) 2009-07-02
BRPI0619475B8 (pt) 2022-03-29
US9724382B2 (en) 2017-08-08
BRPI0619475A2 (pt) 2011-10-04

Similar Documents

Publication Publication Date Title
ATE554746T1 (de) Pharmazeutische zusammensetzungen mit cyclosporin
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
UY30139A1 (es) Formulacion farmaceuica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
WO2004043363A8 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
SG152257A1 (en) Topical preparation containing ambroxol
EA200501586A1 (ru) Фармацевтические продукты
TW200837074A (en) Extended triterpene derivatives
ECSP088403A (es) Formulacion farmaceutica de absorción oral y su método de administracion
TR200100144T2 (tr) Farmasötik aerosol formülasyonu
BR0214199A (pt) Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
AR062775A1 (es) Composicion farmaceutica capaz de mejorar la actividad de glp -1 en un ser humano y su uso para preparar un medicamento
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
UY27727A1 (es) Nueva composicion farmacéutica-
BRPI0511387A (pt) composição e seu uso
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
PE20060484A1 (es) Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
ATE259638T1 (de) Nicht-festes topisch anzuwendendes arzneimittel enthaltend glyzerol und alchemilla vulgaris extrakt
UY27920A1 (es) Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas
WO2008022242A3 (en) Synthesis of propyl phenoxy ethers and use as delivery agents